Reckitt Benckiser pays $1.4 billion in opioid settlement

LONDON — Consumer products company Reckitt Benckiser says it will pay $1.4 billion to resolve U.S. investigations into the marketing of an anti-addiction drug by a subsidiary.

The company said Thursday it reached agreements with the U.S. Department of Justice and the Federal Trade Commission.

The government alleged that an ex-Reckitt subsidiary sought to increase prescriptions for Suboxone Film by deceiving health care providers into believing the drug was safer than other opioid addiction treatments.

Suboxone Film was marketed by RB's former prescription business Indivior, which was spun off in 2014.

The company says it "acted lawfully at all times and expressly denies all allegations that it engaged in any wrongful conduct" but the settlement was in the best interest of RB and shareholders.

It said the settlement would prevent uncertainty and distraction from continued investigations.

Must Read

"La La Land" leads race for British Academy Film...

Jan 10, 2017

Perky, pastel-hued jazz musical "La La Land" leads the race for the British Academy Film Awards,...

Duchess of Cambridge meets families at children's...

Jan 24, 2017

The Duchess of Cambridge has paid an emotional visit to a children's hospice in a village northeast...

Princess Diana statue to mark 20 years since car...

Jan 29, 2017

The sons of the late Princess Diana plan to build a statue to mark the 20th anniversary of her...

Singer Vera Lynn to mark 100th birthday with new...

Feb 2, 2017

Singer Vera Lynn is making plans to mark her 100th birthday with the release of a new album...

Prince William calls for end to stigma on mental...

Feb 7, 2017

Prince William is speaking out about ending the stigma surrounding mental health treatment

Sign up now!